Yanling Ren

819 total citations
51 papers, 516 citations indexed

About

Yanling Ren is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Yanling Ren has authored 51 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 15 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Yanling Ren's work include Acute Myeloid Leukemia Research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). Yanling Ren is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). Yanling Ren collaborates with scholars based in China, United States and Indonesia. Yanling Ren's co-authors include Hongyan Tong, Yizhen Wang, Tizhong Shan, Linhai Zhu, Jie Jin, Wei Zhang, Guo JianFeng, Ting Wu, Xinping Zhou and Chen Mei and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yanling Ren

47 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanling Ren China 12 190 178 95 84 84 51 516
Margit Dlaska Austria 11 232 1.2× 89 0.5× 122 1.3× 101 1.2× 55 0.7× 16 543
Ko‐Tung Chang Taiwan 12 141 0.7× 118 0.7× 140 1.5× 30 0.4× 36 0.4× 29 442
Garry J. Douglas United States 14 146 0.8× 57 0.3× 174 1.8× 128 1.5× 51 0.6× 34 548
Terukazu Tanaka Japan 14 184 1.0× 92 0.5× 95 1.0× 38 0.5× 41 0.5× 50 554
Vít Řeháček Czechia 14 134 0.7× 28 0.2× 164 1.7× 60 0.7× 27 0.3× 33 484
Jaeseon Lee South Korea 14 228 1.2× 32 0.2× 228 2.4× 133 1.6× 33 0.4× 28 646
Traci Heath Mondoro United States 11 158 0.8× 129 0.7× 63 0.7× 118 1.4× 11 0.1× 24 492
Nik Cummings Australia 9 189 1.0× 83 0.5× 74 0.8× 107 1.3× 29 0.3× 12 473
Claire Bardel France 14 122 0.6× 78 0.4× 26 0.3× 38 0.5× 43 0.5× 44 505
Vidyanand Anaparti Canada 12 141 0.7× 39 0.2× 109 1.1× 70 0.8× 48 0.6× 22 466

Countries citing papers authored by Yanling Ren

Since Specialization
Citations

This map shows the geographic impact of Yanling Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Ren more than expected).

Fields of papers citing papers by Yanling Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanling Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Ren. The network helps show where Yanling Ren may publish in the future.

Co-authorship network of co-authors of Yanling Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Yanling Ren. A scholar is included among the top collaborators of Yanling Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanling Ren. Yanling Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Junmin, Yunhui Hao, Mingzhu Gao, et al.. (2025). Highly‐Efficient Low‐Loading Co Atom Sites Catalyst for Hydrogen Generation From Formic Acid. Carbon Energy. 7(12).
2.
Ren, Yanling, Tao Wang, Haiyan Wang, et al.. (2025). Design, Synthesis, Antifungal, and Nematocidal Activities of Novel Pyrimidine Derivatives Incorporating an 1,1,2-Trifluoro-1-butene Moiety. Russian Journal of General Chemistry. 95(2). 511–517.
3.
Li, Yang, Yong Wang, Yanling Ren, et al.. (2024). Prospective cohort study on the clinical significance of interferon-γ, D-dimer, LDH, and CRP tests in children with severe mycoplasma pneumonia. Medicine. 103(41). e39665–e39665. 3 indexed citations
4.
Luo, Yingwan, Xiaomin Feng, Wei Lang, et al.. (2024). Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes. Journal of Clinical Investigation. 134(8). 1 indexed citations
5.
Qiu, Xiaonan, Zhenrui Shi, Si‐Yao Lu, et al.. (2023). TNF-α promotes CXCL-1/8 production in keratinocytes by downregulating galectin-3 through NF-κB and hsa-miR-27a-3p pathway to contribute psoriasis development. Immunopharmacology and Immunotoxicology. 45(6). 692–700. 5 indexed citations
6.
Ye, Li, Liya Ma, Yanling Ren, et al.. (2022). Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 148(4). 845–856. 6 indexed citations
7.
8.
Ren, Yanling, Wei Lang, Chen Mei, et al.. (2022). Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome. Hematological Oncology. 41(1). 159–166. 7 indexed citations
9.
10.
Ren, Yanling & Wei Zhang. (2019). Propofol promotes apoptosis of colorectal cancer cells via alleviating the suppression of lncRNA HOXA11-AS on miRNA let-7i. Biochemistry and Cell Biology. 98(2). 90–98. 28 indexed citations
11.
Luo, Yingwan, Lu Wang, Liya Ma, et al.. (2019). Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes. Cancer Science. 111(2). 580–591. 29 indexed citations
12.
Ye, Li, Yanling Ren, Xinping Zhou, et al.. (2019). Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60 years and has lower toxicities: Comparison with low-dose chemotherapy. Blood Cells Molecules and Diseases. 77. 88–94. 4 indexed citations
13.
Lin, Peipei, Yingwan Luo, Dominic Maggio, et al.. (2018). Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 144(6). 1037–1047. 17 indexed citations
14.
Hu, Chao, Mengxia Yu, Yanling Ren, et al.. (2017). PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation. Scientific Reports. 7(1). 2894–2894. 18 indexed citations
15.
Ma, Liya, et al.. (2016). Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient. IDCases. 6. 109–111. 5 indexed citations
16.
JianFeng, Guo, Tizhong Shan, Ting Wu, et al.. (2010). Comparisons of different muscle metabolic enzymes and muscle fiber types in Jinhua and Landrace pigs1. Journal of Animal Science. 89(1). 185–191. 77 indexed citations
17.
Shan, Tizhong, et al.. (2010). Breed difference and regulation of the porcine Sirtuin 1 by insulin1. Journal of Animal Science. 88(12). 3909–3917. 18 indexed citations
18.
Tong, Hongyan, Yanling Ren, Wenbin Qian, et al.. (2009). Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China. International Journal of Hematology. 90(3). 303–310. 11 indexed citations
19.
Tong, Hongyan, Yanling Ren, Hui Liu, et al.. (2008). Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome. Leukemia & lymphoma. 49(1). 81–87. 59 indexed citations
20.
Tong, Hongyan, Yanling Ren, Feng Xiao, et al.. (2007). Clinical Characteristics of T-Cell Lymphoma Associated Hemophagocytic Syndrome: Comparison of T-Cell Lymphoma with and without Hemophagocytic Syndrome.. Blood. 110(11). 3576–3576. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margit Dlaska Breakdown of academic impact, for papers by Ko‐Tung Chang Breakdown of academic impact, for papers by Garry J. Douglas Breakdown of academic impact, for papers by Terukazu Tanaka Breakdown of academic impact, for papers by Vít Řeháček Breakdown of academic impact, for papers by Jaeseon Lee Breakdown of academic impact, for papers by Traci Heath Mondoro Breakdown of academic impact, for papers by Nik Cummings Breakdown of academic impact, for papers by Claire Bardel Breakdown of academic impact, for papers by Vidyanand Anaparti
Rankless by CCL
2026